255 / 264
Selected Section Materials by Topic
I - 10
Oakley GM, Curtin K, Orb Q, et al. Familial risk of chronic rhinosinusitis with and without nasal
polyposis: genetics or environment.
Int Forum Allergy Rhinol
. 2015; 5(4):276-282. EBM level 3
Orlandi RR, Smith TL, Marple BF, et al. Update on evidence-based reviews with recommendations in
adult chronic rhinosinusitis.
Int Forum Allergy Rhinol
. 2014; 4 Suppl 1: S1-S15. EBM level NA
Poetker DM. Oral corticosteroids in the management of chronic rhinosinusitis with and without nasal
polyps: risks and benefits.
Am J Rhinol Allergy
. 2015; 29(5):339-342. EBM level 5
Smith KA, French G, Mechor B, Rudmik L. Safety of long-term high-volume sinonasal budesonide
irrigations for chronic rhinosinusitis.
Int Forum Allergy Rhinol
. 2016; 6(3):228-232. EBM level 3
Soudry E, Wang J, Vaezeafshar R, et al. Safety analysis of long-term budesonide nasal irrigations in
patients with chronic rhinosinusitis post endoscopic sinus surgery.
Int Forum Allergy Rhinol
. 2016;
6(6):568-572. EBM level 3
Suzuki S, Yasunaga H, Matsui H, et al. Complication rates after functional endoscopic sinus surgery:
analysis of 50,734 Japanese patients.
Laryngoscope
. 2015: 125(8):1785-1791. EBM level 2
Tajudeen BA, Arshi A, Suh JD, et al. Importance of tumor grade in esthesioneuroblastoma survival: a
population-based analysis.
JAMA Otolaryngol Head Neck Surg
. 2014; 140(12):1124-1129. EBM
level NA
Varvyanskaya A, Lopatin A. Efficacy of long-term low-dose macrolide therapy in preventing early
recurrence of nasal polyps after endoscopic sinus surgery.
Int Forum Allergy Rhinol
. 2014; 4(7):533-
541. EBM level 1
Advanced Techniques
Bleier BS, Castelnuovo P, Battaglia P, et al. Endoscopic endonasal orbital cavernous hemangioma
resection: global experience in techniques and outcomes.
Int Forum Allergy Rhinol
. 2016; 6(2):156-161.
EBM level 4
Dixon BJ, Daly MJ, Chan H, et al. Augmented real-time navigation with critical structure proximity
alerts for endoscopic skull base surgery.
Laryngoscope
. 2014; 124(4):853-859. EBM level NA
Harvey RJ, Parmar P, Sacks R, Zanation AM. Endoscopic skull base reconstruction of large dural
defects: a systematic review of published evidence.
Laryngoscope
. 2012; 122(2):452-459. EBM level 3
Allergy
Li JT, Bernstein DI, Calderon MA, et al. Sublingual grass and ragweed immunotherapy: clinical
considerations-a PRACTALL consensus report.
J Allergy Clin Immunol
. 2016; 137(2):369-376. EBM
level 1a
Lin SY, Erekosima N, Kim JM, et al. Sublingual immunotherapy for the treatment of allergic
rhinoconjunctivitis and asthma: a systematic review. JAMA. 2013; 309(12):1278-1288. EBM level 1a